Search clinical trials for: Epelsiban (GSK557296)

Total 7 results

GlaxoSmithKline

Completed

Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers

Embryo Transfer

United States
GlaxoSmithKline

Withdrawn

Placebo-controlled Proof of Concept Study of Epelsiban in Women With Adenomyosis

Adenomyosis

United States
GlaxoSmithKline

Completed

A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

Premature Ejaculation | Obstetric Labour, Premature

United States
GlaxoSmithKline

Completed

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat Dosing

Embryo Transfer

United States
GlaxoSmithKline

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers

Embryo Transfer

United States
GlaxoSmithKline

Completed

A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation

Premature Ejaculation

Netherlands, United States
GlaxoSmithKline

Terminated

A Study to Evaluate Pharmacokinetics, Pharmacodynamics and Tissue Concentrations of Epelsiban

Embryo Transfer

United States

3

Subscribe